Comparative Effectiveness of Combined Favipiravir and Oseltamivir Therapy Versus Oseltamivir Monotherapy in Critically Ill Patients With Influenza Virus Infection

Comparative Outcomes of Adults Hospitalized With Seasonal Influenza A or B Virus Infection: Application of the 7-Category Ordinal Scale

(2019) Yeming Wang et al.   Open Forum Infectious Diseases

Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa

(2019) Timothy M Uyeki et al.   CLINICAL INFECTIOUS DISEASES

Influenza virus polymerase inhibitors in clinical development

(2019) Frederick G. Hayden et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Advances in respiratory virus therapeutics – A meeting report from the 6th isirv Antiviral Group conference

(2019) John H. Beigel et al.   ANTIVIRAL RESEARCH

Oseltamivir resistance in severe influenza A(H1N1)pdm09 pneumonia and acute respiratory distress syndrome: a French multicenter observational cohort study

(2019) Sylvie Behillil et al.   CLINICAL INFECTIOUS DISEASES

Anti-influenza immune plasma for the treatment of patients with severe influenza A: a randomised, double-blind, phase 3 trial

(2019) John H Beigel et al.   Lancet Respiratory Medicine

Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial

(2019) Richard T Davey et al.   Lancet Respiratory Medicine

Prevention and treatment of respiratory viral infections: Presentations on antivirals, traditional therapies and host-directed interventions at the 5th ISIRV Antiviral Group conference

(2018) Jennifer L. McKimm-Breschkin et al.   ANTIVIRAL RESEARCH

The role of adjuvant immunomodulatory agents for treatment of severe influenza

(2018) David S. Hui et al.   ANTIVIRAL RESEARCH

Factors Associated With Prolonged Viral Shedding in Patients With Avian Influenza A(H7N9) Virus Infection

(2018) Yeming Wang et al.   JOURNAL OF INFECTIOUS DISEASES

Dynamic Variation and Reversion in the Signature Amino Acids of H7N9 Virus During Human Infection

(2018) Xiaohui Zou et al.   JOURNAL OF INFECTIOUS DISEASES

Estimates of global seasonal influenza-associated respiratory mortality: a modelling study

(2018) A Danielle Iuliano et al.   LANCET

Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study

(2018) Gerard Moreno et al.   INTENSIVE CARE MEDICINE

Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents

(2018) Frederick G. Hayden et al.   NEW ENGLAND JOURNAL OF MEDICINE

Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial

(2018) Robert W Finberg et al.   JOURNAL OF INFECTIOUS DISEASES

Combination Therapy with Oseltamivir and Favipiravir Delays Mortality but Does Not Prevent Oseltamivir Resistance in Immunodeficient Mice Infected with Pandemic A(H1N1) Influenza Virus

(2018) Mariana Baz et al.   Viruses-Basel

Intravenous zanamivir or oral oseltamivir for hospitalised patients with influenza: an international, randomised, double-blind, double-dummy, phase 3 trial

(2017) Francisco M Marty et al.   Lancet Respiratory Medicine

Immune plasma for the treatment of severe influenza: an open-label, multicentre, phase 2 randomised study

(2017) John H Beigel et al.   Lancet Respiratory Medicine

Meeting report: 4th ISIRV antiviral group conference: Novel antiviral therapies for influenza and other respiratory viruses

(2016) Jennifer L. McKimm-Breschkin et al.   ANTIVIRAL RESEARCH

Adjuvant Corticosteroid Treatment in Adults With Influenza A (H7N9) Viral Pneumonia*

(2016) Bin Cao et al.   CRITICAL CARE MEDICINE

Combinations of Oseltamivir and T-705 Extend the Treatment Window for Highly Pathogenic Influenza A(H5N1) Virus Infection in Mice

(2016) Bindumadhav M. Marathe et al.   Scientific Reports

Evaluation of Intravenous Peramivir for Treatment of Influenza in Hospitalized Patients

(2014) M. D. de Jong et al.   CLINICAL INFECTIOUS DISEASES

Mechanism of Action of T-705 Ribosyl Triphosphate against Influenza Virus RNA Polymerase

(2013) Hidehiro Sangawa et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Favipiravir (T-705), a novel viral RNA polymerase inhibitor

(2013) Yousuke Furuta et al.   ANTIVIRAL RESEARCH

In vitro activity of favipiravir and neuraminidase inhibitor combinations against oseltamivir-sensitive and oseltamivir-resistant pandemic influenza A (H1N1) virus

(2013) E. Bart Tarbet et al.   ARCHIVES OF VIROLOGY

Corticosteroid Treatment in Critically Ill Patients with Pandemic Influenza A/H1N1 2009 Infection

(2011) Sung-Han Kim et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Viral clearance and inflammatory response patterns in adults hospitalized for pandemic 2009 influenza A(H1N1) virus pneumonia

(2011) Nelson Lee et al.   ANTIVIRAL THERAPY

T-705 (favipiravir) activity against lethal H5N1 influenza A viruses

(2009) M. Kiso et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA